Study S000681

Glycaemic Control and Management in Adult Type 2 Diabetes Patients Previously Treated With Premix Insulins and Initiating Treatment With IDegLira in Routine Clinical Practice in Croatia: A 36-week Single Arm, Prospective, Multi-centre, Non-interventional Study

ClinicalTrials.gov record

Registration

Registration: NCT05479591
Acronym: GLIDE
Study type: OBSERVATIONAL
Status: WITHDRAWN
Enrollment: 0
Start: 2022-07-30
Primary completion: 2023-04-30
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:IDegLira
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1271-8967

Registered primary outcomes

Change in Glycated Haemoglobin A1c (HbA1c) [From baseline to end of study (week 36 ± 6 weeks)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.